A "Failed" Assay Development for the Discovery of Rescuing Small Molecules from the Radiation Damage

Area of Science:

• Oncology
• Cell Biology
• Radiotherapy

Background:

• Improving cancer survival necessitates mitigating radiation therapy side effects, particularly in sensitive populations.
• Endothelial cells are crucial targets for radiation damage, impacting treatment efficacy and patient outcomes.
• There is a need for effective preventive or rescue treatments against radiation-induced endothelial damage.

Purpose of the Study:

• To develop a high-throughput in vitro assay for measuring radiation-induced endothelial cell damage.
• To identify small molecules capable of rescuing endothelial cells from radiation damage using phenotypic high-content imaging.
• To share insights and lessons learned from the assay development process.

Main Methods:

• A 96-well microplate-based assay was developed for high-throughput screening.
• Live-cell imaging was employed to observe endothelial cells under various radiation doses and conditions.
• Phenotypic changes and functional assays (nuclear, live-cell, dead-cell staining) were used to assess radiation damage and rescue effects.
• Multiple radiation doses, dose rates, cell densities, and time points (acute and chronic) were investigated.

Main Results:

• The assay allowed for the observation of radiation effects on endothelial cells across diverse experimental conditions.
• Dose-response assessments were performed for known radiation-protective small molecules.
• Despite extensive development, the pilot screening phase was ultimately not pursued.
• Valuable lessons were learned regarding assay optimization and limitations.

Conclusions:

• The developed assay provides a robust platform for evaluating radiation-induced endothelial cell damage and potential rescue strategies.
• The insights gained from this assay development are crucial for future high-throughput screening efforts.
• Further refinement is needed before full-scale screening for novel radioprotective agents can commence.